[ad_1]
OU Health Stephenson Cancer Center joins CARIS’ extensive network of leading cancer institutions committed to using clinical data to improve patient care and outcomes.
IRVING, Texas, August 10, 2022 /PRNewswire/ — Caries Life Sciences®(Caris), a leading molecular science and technology company developing and delivering innovative solutions to transform healthcare, announced today that it has joined OU Health’s Stephenson Cancer Center. Caris Precision Oncology Allianceâ„¢ (POA) POA is a growing network of cancer centers collaborating to advance precision oncology and biomarker-driven research. POA members work together to establish and optimize molecular diagnostic standards of care through innovative research focused on prognostic and prognostic markers that improve clinical outcomes for cancer patients.
available on University of Oklahoma Health Sciences Center in the campus Oklahoma City, Stephens Cancer Center is the state’s only National Cancer Institute (NCI)-designated cancer center, dedicated to patients seeking research-based, patient-centered, multidisciplinary care. It has been named. Oklahoma Advanced Institute for Cancer Care US News and World Report In the 2020-21 ranking, Stephens Cancer Center ranked No. 1 among all cancer centers in the country for the number of people participating in NCI-sponsored clinical trials.
“Stephenson Cancer Center is pleased to join the Caries Precision Oncology Alliance,” he said. Kathleen Moore, MD, professor of gynecologic oncology, Virginia Curley Cade Chair in Cancer Advances Therapeutics and director of the Oklahoma TSET Phase 1 Program. “This partnership will allow us to advance our mission of leveraging innovative platforms to identify potential targetable biomarkers and contribute to innovative research that can be translated into improving the lives of all cancer patients.”
Stephens Cancer Center is committed to reducing the negative impact of cancer Oklahoma And the significant impact on underserved populations in the state will provide training for the next generation of cancer researchers and health professionals. Dedicated cancer research programs at the Stephenson Cancer Center support 135 investigators studying the basic, clinical and behavioral sciences related to cancer care.
“OU Health is excited to welcome the Stephenson Cancer Center to the growing Precision Oncology Alliance network,” he said. Chad Nabhan, MD, MBA, FACP, Chairman of the Caries Precision Oncology Alliance. “The ability to collaborate with Stephenson Cancer Center clinicians and researchers to help improve outcomes for cancer patients by cutting-edge precision oncology research is aligned with the vision of both organizations.”
“Understanding the molecular distributions of each cancer will help match the right patient to the right clinical trial, which will lead to better treatments for all tumor types,” he said. Abdul Rafeh Naqash, MD, assistant professor of medicine and TSET Phase 1 clinical/translational investigator at Stephenson Cancer Center. “We are excited to join the POA network and contribute meaningful research ideas to this collaborative effort.”
The Caries Precision Oncology Alliance includes 70 cancer centers and academic institutions. These institutions have early access to the extensive database and artificial intelligence platform in CARIS to establish evidence-based standards for cancer profiling and molecular diagnostics in oncology. Using the comprehensive genomic, transcriptomic, and proteomic profiles available through Caris Molecular Profiling, Caris wants to use this network to have the ability to prioritize treatment options and determine which clinical trial opportunities may benefit their patients. POA members can also join a portfolio of biopharma-backed biomarker directorates. Additionally, as a POA member, institutions have access to Caris CODEaiâ„¢, the most comprehensive cancer treatment database and clinical outcomes data in the industry.
About the life science of caries
Caris Life Sciences® (Caris) is a leading molecular science and technology company actively developing and delivering innovative solutions to transform healthcare and improve patient outcomes. By applying comprehensive molecular profiling (whole exome and whole transcriptome sequencing) and advanced artificial intelligence (AI) and machine learning algorithms, Karis has created the large-scale clinical-genomic databases and cognitive computing needed to analyze and unravel molecular complexity. Disease. This information provides an unrivaled resource and an excellent means of conducting basic, fundamental research to accelerate discoveries for diagnosis, diagnosis, monitoring, treatment selection and drug development to improve the human condition.
With a primary focus on cancer, Caris’ market-leading molecular profiling offering evaluates DNA, RNA and proteins, revealing a molecular pattern that helps patients, physicians and researchers better diagnose, diagnose and treat patients. Caries’ latest development is blood-based, circulating nucleic acids sequencing (CNAS) research that combines whole-exome and whole-transcriptome sequencing from whole blood and follow-up—the most powerful liquid biopsy test ever developed.
In the headquarters Irving, Texashas offices in Karis. Phoenix, New York, Denver, Tokyo, Japan. And Basel, Switzerland. Karis provides services throughout the US; Europe, Asia and other international markets. To understand more, please visit CarisLifeSciences.com Or follow us on Twitter (@CarisLS).
In Care Of OU Health Stephens Cancer Center
OU Health is the Stephenson Cancer Center. Oklahoma National Cancer Institute-designated cancer center only. Stephens Cancer Center is one of the nation’s top cancer centers, representing 2 percent of all cancer centers in the country. It is the largest and most comprehensive oncology practice in the state, providing patient-centered, multidisciplinary care for every type of cancer. One of the nation’s leading research organizations, Stephenson Cancer Center uses the latest innovations to fight and eradicate cancer and is currently the No. 1 cancer center for patients participating in NCI nationally sponsored clinical trials. Clinical Trials Network. For more information, visit stephensoncancercenter.org.
Karis Life Sciences Media Contact:
Lisa Berger
[email protected]
469.822.9330
OU Health Stephens Cancer Center Media Contact:
April Sandeffer
OU Health Communications Director
[email protected]
405.323.8552
Source Caries Life Sciences
[ad_2]
Source link